Who are clonidine gel 1%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Low-dose Dexmedetomidine, Dexmedetomidine 0.5μg／kg, Intraoperative infusion of dexmedetomidine, Butorphanol and dexmedetomindine, dexmedetomidine 80 µg, Sufentanil and dexmedetomidine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/clonidine-gel-1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

clonidine gel 1% — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

clonidine gel 1% (clonidine gel 1%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Alpha-2 adrenergic agonist. Area: Cardiovascular.

phase 3 Alpha-2 adrenergic agonist Alpha-2 adrenergic receptor Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

clonidine gel 1% (clonidine gel 1%) — Irmandade da Santa Casa de Misericordia de Sao Paulo. Clonidine is an alpha-2 adrenergic agonist that decreases sympathetic nervous system activity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
clonidine gel 1% TARGET	clonidine gel 1%	Irmandade da Santa Casa de Misericordia de Sao Paulo	phase 3	Alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor
Low-dose Dexmedetomidine	Low-dose Dexmedetomidine	Tang-Du Hospital	marketed	Alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor
Dexmedetomidine 0.5μg／kg	Dexmedetomidine 0.5μg／kg	Eye & ENT Hospital of Fudan University	marketed	Alpha-2 adrenergic receptor agonist	Alpha-2 adrenergic receptor
Intraoperative infusion of dexmedetomidine	Intraoperative infusion of dexmedetomidine	Nanjing First Hospital, Nanjing Medical University	marketed	Alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor
Butorphanol and dexmedetomindine	Butorphanol and dexmedetomindine	The Affiliated Hospital of Qingdao University	marketed	Opioid agonist-antagonist combined with alpha-2 adrenergic agonist	Opioid receptors (kappa, sigma, mu) and alpha-2 adrenergic receptors
dexmedetomidine 80 µg	dexmedetomidine 80 µg	Fayoum University Hospital	marketed	Alpha-2 adrenergic receptor agonist	Alpha-2 adrenergic receptor
Sufentanil and dexmedetomidine	Sufentanil and dexmedetomidine	Obstetrics & Gynecology Hospital of Fudan University	marketed	Opioid agonist and alpha-2 adrenergic agonist combination	Mu opioid receptor and alpha-2 adrenergic receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Alpha-2 adrenergic agonist class)

USWM, LLC (dba US WorldMeds) · 2 drugs in this class
China International Neuroscience Institution · 1 drug in this class
Icahn School of Medicine at Mount Sinai · 1 drug in this class
Eye Therapies, LLC · 1 drug in this class
Galderma R&D · 1 drug in this class
Guangzhou Women and Children's Medical Center · 1 drug in this class
Derm Research, PLLC · 1 drug in this class
Irmandade da Santa Casa de Misericordia de Sao Paulo · 1 drug in this class
KK Women's and Children's Hospital · 1 drug in this class
American University of Beirut Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). clonidine gel 1% — Competitive Intelligence Brief. https://druglandscape.com/ci/clonidine-gel-1. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab